Clinical Focus ›› 2022, Vol. 37 ›› Issue (1): 77-80.doi: 10.3969/j.issn.1004-583X.2022.01.015
Previous Articles Next Articles
Received:
2021-12-01
Online:
2022-01-20
Published:
2022-01-20
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2022.01.015
[1] | Schmidt PH, Lee JR, Joshi V, et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma[J]. Lab Investig, 1999, 79(6):639-646. |
[2] |
Engevik AC, Feng R, Choi E, et al. The development of spasmolytic polypeptide/tff2-expressing metaplasia (SPEM) during gastric repair is absent in the aged stomach[J]. Cell Mol Gastroenterol Hepatol, 2016, 2(5):605-624.
pmid: 27990460 |
[3] |
Shimizu T, Choi E, Petersen CP, et al. Characterization of progressive metaplasia in the gastric corpus mucosa of mongolian gerbils infected with Helicobacter pylori[J]. J Pathol, 2016, 239(4):399-410.
doi: 10.1002/path.4735 URL |
[4] |
Shimizu T, Sohn Y, Choi E, et al. Decrease in mir-148a expression during initiation of chief cell transdifferentiation[J]. Cell Mol Gastroenterol Hepatol, 2020, 9(1):61-78.
doi: 10.1016/j.jcmgh.2019.08.008 URL |
[5] |
Bockerstett KA, Osaki LH, Petersen CP, et al. Interleukin-17A promotes parietal cell atrophy by inducing apoptosis[J]. Cell Mol Gastroenterol Hepatol, 2018, 5(4): 678-690.e1.
doi: 10.1016/j.jcmgh.2017.12.012 pmid: 29930985 |
[6] |
Meyer AR, Goldenring JR. Injury, repair, inflammation and metaplasia in the stomach[J]. J Physiol, 2018, 596(17):3861-386.
doi: 10.1113/tjp.2018.596.issue-17 URL |
[7] |
Nam KT, Lee HJ, Sousa JF, et al. Mature chief cells are cryptic progenitors for metaplasia in the stomach[J]. Gastroenterology, 2010, 139(6):2028-2037.e9.
doi: 10.1053/j.gastro.2010.09.005 URL |
[8] |
Radyk MD, Burclaff J, Willet SG, et al. Metaplastic cells in the stomach arise, independently of stem cells, via dedifferentiation or transdifferentiation of chief cells[J]. Gastroenterology, 2018, 154(4): 839-843.e2.
doi: 10.1053/j.gastro.2017.11.278 |
[9] |
Hayakawa Y, Fox JG, Wang TC. Isthmus stem cells are the origins of metaplasia in the gastric corpus[J]. Cell Mol Gastroenterol Hepatol, 2017, 4(1):89-94.
doi: 10.1016/j.jcmgh.2017.02.009 pmid: 28560293 |
[10] |
Hayakawa Y, Ariyama H, Stancikova J, et al. Mist1 expressing gastric stem cells maintain the normal and neoplastic gastric epithelium and are supported by a perivascular stem cell niche[J]. Cancer Cell, 2015, 28(6):800-814.
doi: S1535-6108(15)00380-3 pmid: 26585400 |
[11] |
Fox JG, Rogers AB, Whary MT, et al. Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 -/- C57BL6 x Sv129 Helicobacter pylori-infected mice[J]. Am J Pathol, 2007, 171(5):1520-1528.
doi: 10.2353/ajpath.2007.070249 URL |
[12] |
Hata M, Kinoshita H, Hayakawa Y, et al. GPR30-expressing gastric chief cells do not dedifferentiate but are eliminated via pdk-dependent cell competition during development of metaplasia[J]. Gastroenterology, 2020, 158(6): 1650-1666.e15.
doi: 10.1053/j.gastro.2020.01.046 URL |
[13] |
Petersen CP, Meyer AR, De Salvo C, et al. A signaling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach[J]. Gut, 2018, 67(5):805-817.
doi: 10.1136/gutjnl-2016-312779 URL |
[14] |
Choi E, Hendley AM, Bailey JM, et al. Expression of activated ras in gastric chief cells of mice leads to the full spectrum of metaplastic lineage transitions[J]. Gastroenterology, 2016, 150(4):918-930.
doi: 10.1053/j.gastro.2015.11.049 URL |
[15] |
Shimizu T, Choi E, Petersen CP, et al. Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori[J]. J Pathol, 2016, 239(4):399-410.
doi: 10.1002/path.4735 URL |
[16] |
Krueger S, Kuester D, Bernhardt A, et al. Regulation of cathepsin X overexpression in H.pylori-infected gastric epithelial cells and macrophages[J]. J Pathol, 2009, 217(4):581-588.
doi: 10.1002/path.v217:4 URL |
[17] |
Bernhardt A, Kuester D, Roessner A, et al. Cathepsin X-deficient gastric epithelial cells in co-culture with macrophages: Characterization of cytokine response and migration capability after Helicobacter pylori infection[J]. J Biol Chem, 2010, 285(44):33691-33700.
doi: 10.1074/jbc.M110.146183 pmid: 20736174 |
[18] |
Krueger S, Bernhardt A, Kalinski T, et al. Induction of premalignant host responses by cathepsin x/z-deficiency in Helicobacter pylori-infected mice[J]. PLoS One, 2013, 8(7):e70242.
doi: 10.1371/journal.pone.0070242 URL |
[19] |
Hagen SJ, Ang LH, Zheng Y, et al. Loss of tight junction protein claudin-18 promotes rapid cancer development in mouse stomach[J]. Gastroenterology, 2018, 155(6):1852-1867.
doi: 10.1053/j.gastro.2018.08.041 URL |
[20] |
Winter JA, Letley DP, Cook KW, et al. A role for the vacuolating cytotoxin, VacA, in colonization and Helicobacter pylori-induced metaplasia in the stomach[J]. J Infect Dis, 2014, 210(6):954-963.
doi: 10.1093/infdis/jiu154 pmid: 24625807 |
[21] |
Sáenz JB, Vargas N, Mills JC. Tropism for spasmolytic polypeptide-expressing metaplasia allows helicobacter pylori to expand its intra-gastric niche[J]. Gastroenterology, 2019, 156(1): 160-174.e7.
doi: S0016-5085(18)35081-9 pmid: 30287170 |
[22] |
Halldórsdóttir AM, Sigurdardóttrir M, Jónasson JG, et al. Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland[J]. Dig Dis Sci, 2003, 48(4):431-441.
doi: 10.1023/A:1022564027468 URL |
[23] |
Graham DY, Zou WY. Guilt by association: Intestinal metaplasia does not progress to gastric cancer[J]. Curr Opin Gastroenterol, 2018, 34(6):458-464.
doi: 10.1097/MOG.0000000000000472 URL |
[24] |
Kuo HY, Chang WL, Yeh YC, et al. Spasmolytic polypeptide expressing metaplasia associated with higher expressions of miR-21, 155, and 223 can be regressed by Helicobacter pylori eradication in the gastric cancer familial relatives[J]. Helicobacter, 2019, 24(3):e12578.
doi: 10.1111/hel.2019.24.issue-3 URL |
[25] |
Tsai YC, Hsiao WH, Yang HB, et al. The corpus-predominant gastritis index may serve as an early marker of Helicobacter pylori-infected patients at risk of gastric cancer[J]. Aliment Pharmacol Ther, 2013, 37(10):969-978.
doi: 10.1111/apt.2013.37.issue-10 URL |
[26] | Cheng HC, Tsai YC, Yang HB, et al. The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia[J]. Helicobacter, 2017, 22(4):1-8. |
[27] | Kuo HY, Chang WL, Yeh YC, et al. Serum level of trefoil factor 2 can predict the extent of gastric spasmolytic polypeptide-expressing metaplasia in the H.pylori-infected gastric cancer relatives[J]. Helicobacter, 2017, 22(1):1-8. |
[28] |
Matsuzaki J, Suzuki H, Minegishi Y, et al. Acid suppression by proton pump inhibitors enhances aquaporin-4 and KCNQ1 expression in gastric fundic parietal cells in mouse[J]. Dig Dis Sci, 2010, 55(12):3339-3348.
doi: 10.1007/s10620-010-1167-8 URL |
[29] | Fukuhara S, Matsuzaki J, Tsugawa H, et al. Mucosal expression of aquaporin-4 in the stomach of histamine type 2 receptor knockout mice and Helicobacter pylori-infected mice[J]. J Gastroenterol Hepatol, 2014, (Suppl 4):53-59. |
[30] |
Weis VG, Sousa JF, Lafleur BJ, et al. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression[J]. Gut, 2013, 62(9):1270-1279.
doi: 10.1136/gutjnl-2012-302401 URL |
[1] | Zhao Xuhui, Huang Xiaomin, Da Dezhuan, Xu Yan, Cui Xiaodong, Li Hongling. Screening of glycolysis-related genes for predicting the prognosis of patients with gastric cancer: Based on bioinformatics [J]. Clinical Focus, 2024, 39(1): 20-29. |
[2] | Wang Junhong, Gao Zhenhua, Zhang Ronglong, Ji Haomin, Zhao Xinke, Da Mingxu. Quality analysis of the literatures associated with gastric cancer diagnosis from 1980-2021——A bibliometric analysis based on the Web of Science database [J]. Clinical Focus, 2023, 38(12): 1117-1124. |
[3] | . [J]. Clinical Focus, 2023, 38(11): 1048-1052. |
[4] | Lyu Chang, Zhou Liming. Correlation between the TNF-α-308 gene polymorphism and gastric cancer susceptibility: A meta-analysis [J]. Clinical Focus, 2023, 38(9): 779-787. |
[5] | Wang Yingnan, Zhao Qi, Bai Haiwei, Wu Danna, Wei Jinmei, Li Shengjiang, Li Ruiling, Zhang Ruixing. Clinical characteristics and risk factors of gastric cancer-related stroke [J]. Clinical Focus, 2023, 38(5): 417-422. |
[6] | Tao Jianan, Tian Wangzhao, An Qi, Wang Xuehong, Zhang Shengqi, Liu Ji. Expression and clinical significance of SLP-2 in gastric cancer: A meta-analysis [J]. Clinical Focus, 2022, 37(4): 299-304. |
[7] | Lu Xunda, Feng Zhijie, Ji Chenguang, Yin Kaige, Liu Li. Analysis on risk factors of postoperative hemorrhage of endoscopic submucosal dissection in early gastric cancer [J]. Clinical Focus, 2021, 36(12): 1087-1091. |
[8] | Yuan Shichao, Zhao Qing, Fan Hongyan. Predictive value of dual-energy CT for Ki-67 expression in gastric stromal tumors and relationship with pathological factors [J]. Clinical Focus, 2021, 36(11): 1013-1018. |
[9] | Jin Ying, Wang Pai, Feng Shibing. Application value of Helicobacter pylori, PG and G17 in diagnosing precancerous lesions of gastric cancer [J]. Clinical Focus, 2021, 36(3): 233-237. |
[10] | Chen Jian, Ren Gang, Cai Rong, Zhao Jianxi, Guo Chen, Li Huali. Clinicopathologic characteristics of signet ring cell carcinoma in T1 gastric cancer [J]. Clinical Focus, 2016, 31(2): 207-210. |
[11] | Lu Ming,Liu Hengchang,Wang Quan. Relationship between RacGAP1 expression in gastric cancer and Helicobacter pylori L-type infection [J]. Clinical Focus, 2016, 31(1): 48-52. |
[12] | Su Huyan;Cai Fei;Huang Puwen. Retrospective analysis of prognostic factors for gastric cancer patients who underwent radical resection [J]. Clinical Focus, 2015, 30(12): 1397-1401. |
[13] | Tong Qiaoyun;Zhou Mingdong;Yuan Jinhua;Ge Cunjin. Diagnostic value of endoscopic ultrasonography-guided endoscopy sucosal resection biopsy in Borrmann type Ⅳ gastric cancer [J]. Clinical Focus, 2015, 30(8): 888-890. |
[14] | Jia Zhenjun;Meng Qinglai;Yin Yuewen. Putative role of p53 expression and Hp infection in gastric carcinogenesis [J]. Clinical Focus, 2015, 30(7): 822-824. |
[15] | . [J]. Clinical Focus, 2015, 30(6): 694-697. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||